Energy News Portal

Global

Hantavirus cases spark surge in pharma and biotech stocks — here’s why

Source: International: Top News And Analysis

The outbreak of Hantavirus on a cruise ship has led to biotech and pharmaceutical stocks surging on reports of firms developing vaccines.

View Original Coverage